Home CytoSorbents

CytoSorbents

In operation
Post-IPO Round
Therapeutic Device Developer

Basic Information

CytoSorbents Corporation is a publicly traded critical care focused therapeutic device company using blood purification to treat life-threatening conditions. Its purification technology is based on biocompatible, highly porous polymer beads that actively remove toxic substances from blood and other bodily fluids through pore capture and surface adsorption. Each polymer bead contains millions of pores and channels, which can be modified to remove substances as small as drugs and as large as antibodies.
CytoSorbents Corporation
NewJersey,United States of America
101~500 people
January 01, 1997
info@cytosorbents.com